Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations?
Publication
, Journal Article
Ambrosy, AP; Fudim, M; Chioncel, O
Published in: Eur J Heart Fail
November 2019
Duke Scholars
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
November 2019
Volume
21
Issue
11
Start / End Page
1398 / 1401
Location
England
Related Subject Headings
- Valsartan
- Tetrazoles
- Humans
- Heart Failure
- Drug Combinations
- Cardiovascular System & Hematology
- Biphenyl Compounds
- Aminobutyrates
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ambrosy, A. P., Fudim, M., & Chioncel, O. (2019). Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations? Eur J Heart Fail, 21(11), 1398–1401. https://doi.org/10.1002/ejhf.1555
Ambrosy, Andrew P., Marat Fudim, and Ovidiu Chioncel. “Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations?” Eur J Heart Fail 21, no. 11 (November 2019): 1398–1401. https://doi.org/10.1002/ejhf.1555.
Ambrosy AP, Fudim M, Chioncel O. Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations? Eur J Heart Fail. 2019 Nov;21(11):1398–401.
Ambrosy, Andrew P., et al. “Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations?” Eur J Heart Fail, vol. 21, no. 11, Nov. 2019, pp. 1398–401. Pubmed, doi:10.1002/ejhf.1555.
Ambrosy AP, Fudim M, Chioncel O. Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations? Eur J Heart Fail. 2019 Nov;21(11):1398–1401.
Published In
Eur J Heart Fail
DOI
EISSN
1879-0844
Publication Date
November 2019
Volume
21
Issue
11
Start / End Page
1398 / 1401
Location
England
Related Subject Headings
- Valsartan
- Tetrazoles
- Humans
- Heart Failure
- Drug Combinations
- Cardiovascular System & Hematology
- Biphenyl Compounds
- Aminobutyrates
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology